PerkinElmer: Innovation for a Better Future

Operating in over 150 countries, PerkinElmer is one of the global companies listed on the S&P 500 and the Russell 3000 Indices. The business thrives in the human health and environmental health industries and is headquartered in Waltham, Massachusetts. Registered as an American multinational corporation, the company is traded publicly on the New York Stock Exchange, where its common stocks are marketed under the symbol PKI.

It was in 1937 that Richard Perkin and Charles Elmer founded the company as a consulting and optical design venture. Through its partnership with Cetus Corporation, the company was able to pioneer the industry of polymerase chain reaction (PCR) equipment. Today, the business has diversified its offerings to include genetic testing and diagnostic tools, consumables for multiple end markets, instruments, software, analytical instruments and medical imaging components. Through these offerings, the company is able to make contributions in the industry of life science research, diagnostics, biotechnology, industrial applications, food and consumer product safety and medical imaging. True to its slogan, PerkinElmer is set to produce products “For the Better”.

By manufacturing the products that PerkinElmer carries, the company is able to help scientists and researchers around the world, hasten their studies and the science they do. The solutions the company provides allow health care professionals and scientists create a stronger link between human health and the environment we live in. These products are intended to hasten the development of novel therapeutics to improve patient outcomes, check on the quality of food and water we access and holistically change how we lead our lives and the communities we live in.

There are more than 7,600 associates that are working for PerkinElmer. These individuals continue to explore and wield technology to change our lives for the better. PerkinElmer continues to generate more than $2.2 billion in revenue.